BlackRock Advantage Emerging Markets Fund NSE:SUNPHARMA Holdings History
BlackRock Advantage Emerging Markets Fund's Sun Pharmaceuticals Industries Ltd Holding Summary
As of 2025-04-30, BLACKROCK FUNDS held 24,359.00 shares of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA), totaling ₹528,310.00. This investment constitutes 1.3% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) stock.
The initial trade took place in 2019Q4. And since then BlackRock Advantage Emerging Markets Fund has made 5 purchases of NSE:SUNPHARMA, at an average price of ₹1,058.60, for a total of 90,125.00 shares. In addition, there have been 5 sales at an average price of ₹933.49 for 65,766.00 shares. Based on historical transaction data and NSE:SUNPHARMA's current price of ₹1693.60, BlackRock Advantage Emerging Markets Fund's estimated gain on his NSE:SUNPHARMA holdings is ₹7.24 Mil, reflecting a 7.59% gain to date.
BlackRock Advantage Emerging Markets Fund NSE:SUNPHARMA (₹1693.60) Holding Chart
BlackRock Advantage Emerging Markets Fund NSE:SUNPHARMA (₹1693.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price ₹-/Share | ||
| Shares Sold | 0 | Average Price ₹-/Share | ||
| Current Price ₹0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
